
"Sector" = median of Consumer Defensive across 72 companies
Kenvue Inc. is a global consumer health company formed from Johnson & Johnson's consumer health division. It specializes in household and personal products, including well-known brands like Tylenol, Neutrogena, Listerine, and Band-Aid. The company focuses on everyday health and wellness, offering products that range from over-the-counter medicines to skincare and oral care. Kenvue operates in the consumer defensive sector, providing essential items that maintain steady demand regardless of economic conditions.
Kenvue generates revenue through the sale of branded consumer health products across three segments: Self Care (e.g., pain relievers, cold remedies), Skin Health & Beauty (e.g., moisturizers, sunscreens), and Essential Health (e.g., oral care, baby care). Its business model relies on strong brand recognition, extensive distribution networks, and continuous innovation. The company's gross margin of 58.13% reflects its ability to command premium pricing for trusted brands, while its operating margin of 17.95% indicates efficient cost management.
In the household and personal products industry, Kenvue competes with giants like Procter & Gamble, Unilever, and Colgate-Palmolive. Its competitive positioning is strengthened by its heritage from Johnson & Johnson, a portfolio of iconic brands, and a focus on science-backed products. With a market cap of $32.34 billion and a P/E ratio of 19.87, Kenvue is considered a stable, defensive investment. The company's EV/EBITDA of 11.96 suggests reasonable valuation relative to earnings.
Kenvue's target audience includes consumers seeking trusted, everyday health and hygiene products. Its products are sold in over 100 countries, with a strong presence in North America, Europe, and emerging markets. The company's customer base spans all age groups, from infants (baby care) to seniors (pain relief). Kenvue's dividend yield of 4.84% appeals to income-focused investors, while its free cash flow yield of 5.40% indicates solid cash generation.
An auto-generated descriptive profile based on company data, for informational purposes only.
No 24-hour summary has been generated yet.
Latest saved period: March 2026 · 2026-03-31
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Feb 11, 2026 | $0.21 | Feb 25, 2026 | Quarterly |
| Nov 12, 2025 | $0.21 | Nov 26, 2025 | Quarterly |
| Aug 13, 2025 | $0.21 | Aug 27, 2025 | Quarterly |
| May 14, 2025 | $0.21 | May 28, 2025 | Quarterly |
| Feb 12, 2025 | $0.21 | Feb 26, 2025 | Quarterly |
| Nov 13, 2024 | $0.21 | Nov 27, 2024 | Quarterly |
| Aug 14, 2024 | $0.21 | Aug 28, 2024 | Quarterly |
| May 7, 2024 | $0.20 | May 22, 2024 | Quarterly |
| Feb 13, 2024 | $0.20 | Feb 28, 2024 | Quarterly |
| Nov 7, 2023 | $0.20 | Nov 22, 2023 | Quarterly |
| Aug 25, 2023 | $0.20 | Sep 7, 2023 | Other |
Wrqti brings Kenvue Inc. data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the Consumer Defensive sector you can compare with Kenvue Inc.:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Latest financial period shown: March 2026.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.